| Literature DB >> 28408833 |
Adriana Mira1, Juana Bretón-López1,2, Azucena García-Palacios1,2, Soledad Quero1,2, Rosa María Baños2,3, Cristina Botella1,2.
Abstract
PURPOSE: The purpose of this study was to analyze the efficacy of an Internet-based program for depressive symptoms using automated support by information and communication technologies (ICTs) and human support. PATIENTS AND METHODS: An Internet-based program was used to teach adaptive ways to cope with depressive symptoms and daily problems. A total of 124 participants who were experiencing at least one stressful event that caused interference in their lives, many of whom had clinically significant depressive symptoms, were randomly assigned into either an intervention group with ICT support (automated mobile phone messages, automated emails, and continued feedback through the program); an intervention group with ICT support plus human support (brief weekly support phone call without clinical content); or a waiting-list control. At pre-, post-, and 12-month follow-up, they completed depression, anxiety, positive and negative effect, and perceived stress measures. Results were analyzed using both intention-to-treat and completers data. The majority were women (67.7%), with a mean age of 35.6 years (standard deviation =9.7).Entities:
Keywords: adherence; depressive symptomatology; online intervention; satisfaction; types of support
Year: 2017 PMID: 28408833 PMCID: PMC5384701 DOI: 10.2147/NDT.S130994
Source DB: PubMed Journal: Neuropsychiatr Dis Treat ISSN: 1176-6328 Impact factor: 2.570
Demographic characteristics of participants at pre-assessment
| Variables | IG | IGHS | WL | Total |
|---|---|---|---|---|
| Gender | ||||
| Male | 13 (36.1%) | 15 (34.1%) | 12 (27.3%) | 40 (32.3%) |
| Female | 23 (63.9%) | 29 (65.9%) | 32 (72.7%) | 84 (67.7%) |
| Marital status | ||||
| Single | 20 (55.6%) | 23 (52.3%) | 20 (45.5%) | 63 (50.8%) |
| Married/with partner | 12 (33.3%) | 19 (43.2%) | 20 (45.5%) | 51 (41.1%) |
| Divorced | 4 (11.1%) | 2 (4.5%) | 4 (9.1%) | 10 (8.1%) |
| Education level | ||||
| High school graduate or less | 1 (2.8%) | 3 (6.8%) | 3 (6.8%) | 7 (5.6%) |
| Some college | 9 (25%) | 12 (27.3%) | 7 (15.9%) | 28 (22.6%) |
| College graduate or graduate degree | 26 (72.2%) | 29 (65.9%) | 34 (77.3%) | 89 (71.8%) |
| Age | ||||
| Rank | 20–59 | 20–53 | 21–58 | 20–59 |
| M | 35.22 | 35.05 | 36.48 | 35.60 |
| SD | 9.70 | 9.36 | 10.17 | 9.70 |
Abbreviations: M, mean; SD, standard deviation; IG, intervention group (N=36); IGHS, intervention group with human support (N=44); WL, waiting list control condition (N=44).
Specific objectives, content, and exercises of intervention modules
| Intervention modules | Main objective | Module content | Exercises |
|---|---|---|---|
| 1. Motivation for change | To analyze the advantages and disadvantages of change | Motivation and its importance for treatment | Fill out the Decisional Balance Board and reflect on the pros and cons of change |
| 2. Understanding emotional problems | To provide information so that the user can understand emotional problems | Stress, depression, and other emotional responses | Know some typical responses to adverse events |
| 3. Learning to move on | To teach the importance of “moving on” to acquire a proper level of activity and involvement in life | The role of the activity in our well-being | Know why it is important to register the activities carried out every day |
| 4. Learning to be flexible | To teach a more flexible way of thinking | Our interpretation of the situations influences our feelings | Practice the identification of Erroneous Thoughts and Cognitive |
| 5. Learning to enjoy | To promote involvement in pleasant and significant activities and in having contact with other people | The role of positive emotions in our lives | Divide the week between smile days and non-smile days |
| 6. Learning to live | To understand the importance of identifying the individual’s own psychological strengths and carrying out meaningful activities linked to values and goals in life | The concept of well-being and psychological “strengths” | Select and record activities linked to values and significant areas of life |
| 7. Living and learning | To develop an action plan to boost the individual’s psychological strengths | What strengths are important to you? What strengths do you want to strengthen? | Gratitude: |
| 8. From now on, what else…? | To strengthen what was learned during the program | What have I learned? | Summarizing the things learned in each module |
Figure 1Structured protocol for the type of support provided to participants.
Abbreviation: ICT, information and communication technology.
Figure 2Flowchart of study.
Abbreviations: IG, intervention group; IGHS, intervention group with human support; WL, waiting list control condition.
Clinical characteristics of participants at pre-assessment
| Dependent variable | Condition | M | SD | ||
|---|---|---|---|---|---|
| BDI-II | IG | 9.14 | 7.66 | 0.84 | 0.436 |
| IGHS | 10.91 | 6.96 | |||
| WL | 9.11 | 7.47 | |||
| Total | 9.76 | 7.34 | |||
| OASIS | IG | 4.06 | 3.65 | 2.02 | 0.137 |
| IGHS | 4.43 | 3.66 | |||
| WL | 3.00 | 3.04 | |||
| Total | 3.81 | 3.47 | |||
| ODSIS | IG | 2.53 | 3.16 | 1.10 | 0.336 |
| IGHS | 3.30 | 3.52 | |||
| WL | 2.27 | 3.34 | |||
| Total | 2.71 | 3.35 | |||
| PANAS+ | IG | 29.22 | 8.72 | 0.47 | 0.625 |
| IGHS | 27.86 | 6.91 | |||
| WL | 29.34 | 7.92 | |||
| Total | 28.78 | 7.79 | |||
| PANAS− | IG | 18.11 | 6.85 | 1.00 | 0.372 |
| IGHS | 19.50 | 5.95 | |||
| WL | 17.68 | 6.10 | |||
| Total | 18.45 | 6.28 | |||
| PSS | IG | 5.86 | 2.74 | 8.53 | <0.001 |
| IGHS | 6.25 | 3.24 | |||
| WL | 8.07 | 1.59 | |||
| Total | 6.78 | 2.76 |
Abbreviations: M, mean; SD, standard deviation; IG, intervention group (N=36); IGHS, intervention group with human support (N=44); WL, waiting list control condition (N=44); BDI-II, Beck Depression Inventory-II; OASIS, Overall Anxiety Severity and Impairment Scale; ODSIS, Overall Depression Severity and Impairment Scale; PANAS+, Positive Affect Scale; PANAS−, Negative Affect Scale; PSS, Perceived Stress Scale.
Means, SDs, within-group, and between-group effect sizes for the outcome measures at pre- and posttreatment (completer and ITT sample)
| N; mean (SD)
| Within-group effect size, | Between-group effect size, | ||||
|---|---|---|---|---|---|---|
| Pretreatment | Posttreatment | |||||
| BDI-II | IG | 28; 8.32 (7.13) | 28; 3.04 (2.74) | 0.72 (0.17; 1.26) | IG vs IGHS | 0.40 (−0.90; 0.10) |
| IGHS | 36; 10.36 (7.28) | 36; 4.56 (4.39) | 0.78 (0.40; 1.16) | IG vs WL | 0.90 (−1.40; −0.40) | |
| WL | 44; 9.11 (7.47) | 44; 8.45 (7.32) | 0.09 (−0.10; 0.28) | IGHS vs WL | 0.62 (−1.74; −0.17) | |
| Total | 108; 9.32 (7.30) | 108; 5.75 (5.93) | ||||
| OASIS | IG | 28; 3.64 (3.68) | 28; 1.46 (2.13) | 0.58 (0.13; 1.01) | IG vs IGHS | 0.19 (−0.29; 0.69) |
| IGHS | 36; 4.28 (3.87) | 36; 1.08 (1.73) | 0.81 (0.32; 1.29) | IG vs WL | 0.57 (−1.06; −0.09) | |
| WL | 44; 3.00 (3.04) | 44; 3.34 (3.77) | 0.11 (−0.32; 0.10) | IGHS vs WL | 0.74 (−1.20; −0.28) | |
| Total | 108; 3.59 (3.51) | 108; 2.10 (2.99) | ||||
| ODSIS | IG | 28; 2.29 (3.16) | 28; 0.54 (1.32) | 0.54 (0.02; 1.05) | IG vs IGHS | 0.11 (−0.60; 0.38) |
| IGHS | 36; 3.17 (3.68) | 36; 0.72 (1.75) | 0.65 (0.19; 1.10) | IG vs WL | 0.57 (−1.06; −0.09) | |
| WL | 44; 2.27 (3.34) | 44; 2.23 (3.57) | 0.01 (−0.22; 0.25) | IGHS vs WL | 0.51 (−0.96; −0.07) | |
| Total | 108; 2.57 (3.41) | 108; 1.29 (2.68) | ||||
| PANAS+ | IG | 28; 30.32 (8.91) | 28; 32.50 (8.51) | 0.24 (−0.18; 0.65) | IG vs IGHS | 0.05 (−0.44, 0.54) |
| IGHS | 36; 28.19 (6.96) | 36; 32.97 (8.24) | 0.67 (0.29; 1.04) | IG vs WL | 0.32 (−0.80; 0.15) | |
| WL | 44; 29.34 (7.92) | 44; 29.91 (7.58) | 0.07 (−0.31; 0.46) | IGHS vs WL | 0.38 (−0.83; 0.06) | |
| Total | 108; 29.21 (7.86) | 108; 31.60 (8.10) | ||||
| PANAS− | IG | 28; 18.07 (7.19) | 28; 13.04 (3.32) | 0.68 (0.22; 1.13) | IG vs IGHS | 0.04 (−0.53; 0.45) |
| IGHS | 36; 19.03 (6.19) | 36; 13.19 (3.82) | 0.92 (0.51; 1.33) | IG vs WL | 0.84 (−1.34; −0.35) | |
| WL | 44; 17.68 (6.10) | 44; 17.93 (6.80) | 0.04 (−0.44; 0.36) | IGHS vs WL | 0.82 (−1.28; −0.37) | |
| Total | 108; 18.23 (6.40) | 108; 15.08 (5.63) | ||||
| PSS | IG | 28; 5.64 (2.73) | 28; 4.25 (2.35) | 0.49 (0.13; 0.85) | IG vs IGHS | 0.02 (−0.52; 0.46) |
| IGHS | 36; 6.03 (3.32) | 36; 4.33 (3.23) | 0.50 (0.13; 0.86) | IG vs WL | 1.92 (−2.49; −1.35) | |
| WL | 44; 8.07 (1.59) | 44; 8.09 (1.70) | 0.01 (−0.31; 0.29) | IGHS vs WL | 1.49 (−1.98; −0.99) | |
| Total | 108; 6.76 (2.78) | 108; 5.84 (3.08) | ||||
| BDI-II | IG | 36; 9.14 (7.66) | 36; 5.03 (6.09) | 0.52 (0.18; 0.86) | IG vs IGHS | 0.20 (−0.63; 0.25) |
| IGHS | 44; 10.91 (6.96) | 44; 6.16 (5.61) | 0.67 (0.35; 0.98) | IG vs WL | 0.50 (−0.94; −0.05) | |
| WL | 44; 9.11 (7.47) | 44; 8.45 (7.32) | 0.09 (−0.10; 0.28) | IGHS vs WL | 0.34 (−0.76; 0.07) | |
| Total | 124; 9.76 (7.34) | 124; 6.65 (6.50) | ||||
| OASIS | IG | 36; 4.06 (3.65) | 36; 1.92 (2.52) | 0.57 (0.21; 0.93) | IG vs IGHS | 0.10 (−0.33; 0.54) |
| IGHS | 44; 4.43 (3.66) | 44; 1.66 (2.47) | 0.74 (0.40; 1.08) | IG vs WL | 0.43 (−0.88; 0.02) | |
| WL | 44; 3.00 (3.04) | 44; 3.34 (3.77) | 0.11 (−0.33; 0.11) | IGHS vs WL | 0.52 (−0.95; −0.09) | |
| Total | 124; 3.81 (3.47) | 124; 2.33 (3.08) | ||||
| ODSIS | IG | 36; 2.53 (3.16) | 36; 0.86 (1.78) | 0.52 (0.12; 0.90) | IG vs IGHS | 0.25 (−0.69; 0.19) |
| IGHS | 44; 3.30 (3.52) | 44; 1.43 (2.56) | 0.52 (0.13; 0.90) | IG vs WL | 0.50 (−0.95; −0.05) | |
| WL | 44; 2.27 (3.34) | 44; 2.23 (3.57) | 0.01 (−0.22; 0.24) | IGHS vs WL | 0.29 (−0.70; 0.13) | |
| Total | 124; 2.71 (3.35) | 124; 1.55 (2.82) | ||||
| PANAS+ | IG | 36; 29.22 (8.72) | 36; 31.31 (9.08) | 0.23 (−0.10; 0.57) | IG vs IGHS | 0.03 (−0.41; 0.47) |
| IGHS | 44; 27.86 (6.91) | 44; 31.61 (9.35) | 0.53 (0.23; 0.83) | IG vs WL | 0.17 (−0.61; 0.27) | |
| WL | 44; 29.34 (7.92) | 44; 29.91 (7.58) | 0.07 (−0.31; 0.45) | IGHS vs WL | 0.20 (−0.62; 0.22) | |
| Total | 124; 28.78 (7.79) | 124; 30.92 (8.64) | ||||
| PANAS− | IG | 36; 18.11 (6.85) | 36; 13.81 (3.66) | 0.61 (0.22; 1.00) | IG vs IGHS | 0.08 (−0.51; 0.36) |
| IGHS | 44; 19.50 (5.95) | 44; 14.14 (4.68) | 0.89 (0.53; 1.24) | IG vs WL | 0.72 (−1.18; −0.27) | |
| WL | 44; 17.68 (6.10) | 44; 17.93 (6.80) | 0.04 (−0.44; 0.36) | IGHS vs WL | 0.64 (−1.72; −0.21) | |
| Total | 124; 18.45 (6.28) | 124; 15.39 (5.59) | ||||
| PSS | IG | 36; 5.86 (2.74) | 36; 4.78 (2.62) | 0.39 (0.01; 0.75) | IG vs IGHS | 0.02 (−0.47; 0.41) |
| IGHS | 44; 6.25 (3.24) | 44; 4.86 (3.32) | 0.42 (0.09; 0.74) | IG vs WL | 1.51 (−2.01; −1.02) | |
| WL | 44; 8.07 (1.59) | 44; 8.09 (1.70) | 0.01 (−0.30; 0.28) | IGHS vs WL | 1.20 (−1.66; −0.75) | |
| Total | 124; 6.78 (2.76) | 124; 5.98 (3.05) | ||||
Abbreviations: SD, standard deviation; ITT, intention-to-treat; IG, intervention group; IGHS, intervention group with human support; WL, waiting list control condition; BDI-II, Beck Depression Inventory-II; OASIS, Overall Anxiety Severity and Impairment Scale; ODSIS, Overall Depression Severity and Impairment Scale; PANAS+, Positive Affect Scale; PANAS−, Negative Affect Scale; PSS, Perceived Stress Scale; CI, confidence interval.
Means, SDs, within-group and between-group effect sizes for the outcome measures at pretreatment, posttreatment, and 12-month follow-up (completer and ITT sample)
| N; mean (SD)
| Within-group effect size, | Between-group effect size, | |||||
|---|---|---|---|---|---|---|---|
| Pretreatment | Posttreatment | Follow-up (12 months) | Pre-follow-up (12 months) | Group | Follow-up (12 months) | ||
| BDI-II | IG | 20; 8.30 (7.26) | 20; 2.60 (2.78) | 20; 3.25 (4.10) | 0.67 (0.11; 1.21) | IG vs IGHS | 0.15 (−0.74; 0.44) |
| IGHS | 25; 10.52 (7.56) | 25; 4.80 (4.59) | 25; 4.04 (5.69) | 0.83 (0.36; 1.29) | |||
| Total | 45; 9.53 (7.42) | 45; 3.82 (4.01) | 45; 3.69 (5.01) | ||||
| OASIS | IG | 20; 3.35 (3.35) | 20; 1.45 (2.04) | 20; 1.65 (2.58) | 0.49 (−0.13; 1.10) | IG vs IGHS | 0.14 (−0.73; 0.45) |
| IGHS | 25; 3.84 (3.84) | 25; 0.80 (1.58) | 25; 2.04 (2.95) | 0.45 (−0.05; 1.02) | |||
| Total | 45; 3.62 (3.62) | 45; 1.09 (1.81) | 45; 1.87 (2.77) | ||||
| ODSIS | IG | 20; 2.30 (2.72) | 20; 0.40 (.883) | 20; 0.85 (2.13) | 0.51 (0.00; 1.02) | IG vs IGHS | 0.17 (−0.76; 0.42) |
| IGHS | 25; 3.08 (3.99) | 25; 0.64 (1.440) | 25; 1.24 (2.31) | 0.45 (−0.02; 0.92) | |||
| Total | 45; 2.73 (3.47) | 45; 0.53 (1.217) | 45; 1.07 (2.22) | ||||
| PANAS+ | IG | 20; 29.95 (10.25) | 20; 32.25 (9.65) | 20; 34.50 (6.79) | 0.43 (−0.08; 0.93) | IG vs IGHS | 0.23 (−0.83; 0.35) |
| IGHS | 25; 28.04 (6.01) | 25; 32.08 (8.07) | 25; 32.92 (6.34) | 0.79 (0.33; 1.23) | |||
| Total | 45; 28.89 (8.13) | 45; 32.16 (8.71) | 45; 33.62 (6.52) | ||||
| PANAS− | IG | 20; 17.35 (6.12) | 20; 12.60 (3.12) | 20; 13.90 (4.28) | 0.54 (0.13; 0.95) | IG vs IGHS | 0.10 (−0.69; 0.49) |
| IGHS | 25; 19.16 (6.74) | 25; 13.12 (3.81) | 25; 14.28 (2.98) | 0.70 (0.29; 1.10) | |||
| Total | 45; 18.36 (6.46) | 45; 12.89 (3.49) | 45; 14.11 (3.58) | ||||
| PSS | IG | 20; 5.60 (2.80) | 20; 4.10 (2.34) | 20; 4.35 (2.62) | 0.43 (0.00; 0.86) | IG vs IGHS | 0.02 (−0.60; 0.57) |
| IGHS | 25; 6.20 (3.27) | 25; 4.52 (3.19) | 25; 4.40 (2.43) | 0.53 (0.10; 0.96) | |||
| Total | 45; 5.93 (3.05) | 45; 4.33 (2.82) | 45; 4.38 (2.49) | ||||
| BDI-II | IG | 36; 9.14 (7.66) | 36; 5.03 (6.09) | 36; 5.61 (6.44) | 0.45 (0.13; 0.76) | IG vs IGHS | 0.03 (−0.47; 0.40) |
| IGHS | 44; 10.91 (6.96) | 44; 6.16 (5.61) | 44; 5.84 (6.51) | 0.72 (0.38; 1.52) | |||
| Total | 80; 10.11 (6.96) | 80; 5.65 (5.82) | 80; 5.74 (6.44) | ||||
| OASIS | IG | 36; 4.06 (3.65) | 36; 1.92 (2.52) | 36; 2.33 (2.88) | 0.46 (0.10; 0.82) | IG vs IGHS | 0.06 (−0.50; 0.38) |
| IGHS | 44; 4.43 (3.66) | 44; 1.66 (2.47) | 44; 2.52 (3.05) | 0.51 (0.14; 0.87) | |||
| Total | 80; 4.26 (3.63) | 80; 1.78 (2.48) | 80; 2.44 (2.99) | ||||
| ODSIS | IG | 36; 2.53 (3.16) | 36; 0.86 (1.78) | 36; 1.11 (2.19) | 0.44 (0.12; 0.75) | IG vs IGHS | 0.32 (−0.76; 0.12) |
| IGHS | 44; 3.30 (3.52) | 44; 1.43 (2.56) | 44; 1.95 (2.89) | 0.38 (0.00; 0.75) | |||
| Total | 80; 2.95 (3.36) | 80; 1.18 (2.24) | 80; 1.58 (2.61) | ||||
| PANAS+ | IG | 36; 29.22 (8.72) | 36; 31.31 (9.08) | 36; 32.53 (7.66) | 0.37 (0.02; 0.72) | IG vs IGHS | 0.08 (−0.51; 0.36) |
| IGHS | 44; 27.86 (6.91) | 44; 31.61 (9.35) | 44; 31.93 (7.97) | 0.58 (0.26; 0.89) | |||
| Total | 80; 28.48 (7.76) | 80; 31.48 (9.18) | 80; 32.20 (7.79) | ||||
| PANAS− | IG | 36; 18.11 (6.85) | 36; 13.81 (3.66) | 36; 14.94 (4.21) | 0.45 (0.13; 0.77) | IG vs IGHS | 0.07 (−0.50; 0.37) |
| IGHS | 44; 19.50 (5.95) | 44; 14.14 (4.68) | 44; 15.25 (4.66) | 0.70 (0.36; 1.04) | |||
| Total | 80; 18.88 (6.37) | 80; 13.99 (4.23) | 80; 15.11 (4.44) | ||||
| PSS | IG | 36; 5.86 (2.74) | 36; 4.78 (2.62) | 36; 4.81 (2.80) | 0.37 (0.10; 0.64) | IG vs IGHS | 0.01 (−0.43; 0.45) |
| IGHS | 44; 6.25 (3.24) | 44; 4.86 (3.32) | 44; 4.77 (2.79) | 0.45 (0.15; 0.73) | |||
| Total | 80; 6.08 (3.01) | 80; 4.83 (3.01) | 80; 4.79 (2.77) | ||||
Abbreviations: SD, standard deviation; ITT, intention-to-treat; IG, intervention group; IGHS, intervention group with human support; BDI-II, Beck Depression Inventory-II; OASIS, Overall Anxiety Severity and Impairment Scale; ODSIS, Overall Depression Severity and Impairment Scale; PANAS+, Positive Affect Scale; PANAS−, Negative Affect Scale; PSS, Perceived Stress Scale; CI, confidence interval.
Means and SDs for expectations and satisfaction
| Statements | Expectations N; mean (SD) | Satisfaction N; mean (SD) |
|---|---|---|
| How logical do you think this treatment is? | ||
| Total sample | 76; 7.57 (1.79) | 64; 8.14 (1.56) |
| IG | 33; 7.48 (1.64) | 28; 8.21 (1.77) |
| IGHS | 43; 7.63 (1.92) | 36; 8.08 (1.40) |
| How satisfied are you with the treatment received? | ||
| Total sample | 76; 7.28 (1.92) | 64; 7.88 (1.74) |
| IG | 33; 7.42 (1.79) | 28; 7.93 (1.92) |
| IGHS | 43; 7.16 (2.02) | 36; 7.83 (1.61) |
| To what extent do you feel confident recommending this treatment to a friend who has the same problems? | ||
| Total sample | 76; 7.64 (2.12) | 64; 8.33 (1.79) |
| IG | 33; 7.58 (2.03) | 28; 8.25 (1.96) |
| IGHS | 43; 7.70 (2.21) | 36; 8.39 (1.68) |
| Do you think this treatment could be useful for treating other | ||
| Total sample | 76; 7.46 (2.00) | 64; 8.09 (1.76) |
| IG | 33; 7.18 (1.98) | 28; 8.04 (1.92) |
| IGHS | 43; 7.67 (2.02) | 36; 8.14 (1.66) |
| To what extent do you think the treatment was helpful to you? | ||
| Total sample | 76; 6.86 (2.21) | 64; 7.36 (1.99) |
| IG | 33; 6.76 (2.12) | 28; 7.46 (2.03) |
| IGHS | 43; 6.93 (2.31) | 36; 7.28 (1.98) |
Note: Scale ranging from 0 to 10 with higher scores indicating greater satisfaction.
Abbreviations: SD, standard deviation; IG, intervention group; IGHS, intervention group with human support.